TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

SPECTRUM PHARMS

OncologyInfectious Disease
Specialty

SPECTRUM PHARMS is a specialty pharmaceutical company focused on Oncology, Infectious Disease.

1962
Since
3
Drugs
-
Trials
36
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

FLUOROURACIL 2026-02-10
Labeling
FLUOROURACIL 2026-02-10
Labeling
FLUOROURACIL 2026-02-05
Labeling
FLUOROURACIL 2026-02-05
Labeling
FLUOROURACIL 2026-02-05
Labeling
FLUOROURACIL 2026-02-05
Labeling
FLUOROURACIL 2026-02-05
Labeling
FLUOROURACIL 2026-02-05
Labeling
FLUOROURACIL 2026-02-05
Labeling
FLUOROURACIL 2026-02-05
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 67%
2 drugs
Infectious Disease 33%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Oncology, Infectious Disease
Merck big-pharma
Oncology, Infectious Disease
Baxter specialty
Infectious Disease, Oncology
AbbVie big-pharma
Oncology, Infectious Disease
Johnson & Johnson big-pharma
Oncology, Infectious Disease